Summary Delphi Genetics SA (Delphi Genetics) is a genetic engineering and bio productions company that develops products and technologies for gene cloning and protein expression in bacteria.The company’s services include gene synthesis, DNA cloning and mutagenesis plasmid production, protein immunization, customized recombinant protein production, andQ-PCR analysis, among others.
It develops products based on a bacterial poison antidote genes technology.Delphi Genetics’ technologies find applications in PCR cloning, staby cloning, protein expression, vector adaptation, DNA immunization, reagents and competent cells.
The company markets its products through its distribution networks across the US, Germany, Austria, Singapore, Malaysia, Indonesia and Japan. Delphi Genetics is headquartered in Charleroi, Belgium.
Delphi Genetics SA - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings.The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period.
The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.
Scope - Financial Deals - Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships. - Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period. - Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc. - Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America. - Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector. - Major Deals - Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios. - Business Description - A brief description of the company’s operations. - Key Employees - A list of the key executives of the company. - Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company. - Key Competitors - A list of the key competitors of the company. - Key Recent Developments - A brief on recent news about the company.
Reasons to Buy Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements - The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company’s business segments’ expansion / divestiture strategy - The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.
Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company - Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.
Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers. - The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company - Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research - Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
Our reports have been used by over 10K customers, including:
The cooler box market is estimated to be valued at USD 4.6 billion in 2020 and is projected to reach USD 8.1 billion by 2025, at a CAGR of 12.1% from 2020 to 2025 Growth in the pharmaceutical industry, ongoing COVID-19 vaccination drives, transportation of processed and fresh fruits, vegetables, dairy products, and other perishable food products...
In-depth Analysis and Data-driven Insights on the Impact of COVID-19 Included in this Global IV and Oral Iron Drugs Market Report
The global IV and oral iron drugs market by revenue is expected to grow at a CAGR of 11.6% during the period 2021–2026.
The global IV and oral iron drugs market is expected to grow due to the prevalence...
The global blister packaging market reached a value of US$ 21.3 Billion in 2020. Blister packaging refers to a pre-formed plastic packaging which comprises of a cavity that is made using a thermoformed plastic and a paper or aluminum foil back. This type of packaging displays a large part of the content to consumers while protecting it from...
137 pages •
By Global Industry Analysts
• Apr 2021
Abstract:
- Global Nanosilver Market to Reach $3 Billion by 2027
- Amid the COVID-19 crisis, the global market for Nanosilver estimated at US$1.1 Billion in the year 2020, is projected to reach a revised size of US$3 Billion by 2027, growing at a CAGR of 14.9% over the analysis period 2020-2027. Electrical and Electronics,...
376 pages •
By Global Industry Analysts
• Apr 2021
Abstract:
- Global Computed Tomography (CT) Scanners Market to Reach $6.9 Billion by 2027
- Amid the COVID-19 crisis, the global market for Computed Tomography (CT) Scanners estimated at US$5.3 Billion in the year 2020, is projected to reach a revised size of US$6.9 Billion by 2027, growing at a CAGR of 3.8% over...
216 pages •
By Global Industry Analysts
• Apr 2021
Abstract:
- Global Private Healthcare Market to Reach $7.4 Trillion by 2027
- Amid the COVID-19 crisis, the global market for Private Healthcare estimated at US$4.7 Trillion in the year 2020, is projected to reach a revised size of US$7.4 Trillion by 2027, growing at a CAGR of 6.7% over the period 2020-2027.
-...
240 pages •
By Global Industry Analysts
• Apr 2021
Abstract:
- Global Virtual Reality (VR) In Healthcare Market to Reach $2.2 Billion by 2027
- Amid the COVID-19 crisis, the global market for Virtual Reality (VR) In Healthcare estimated at US$336.9 Million in the year 2020, is projected to reach a revised size of US$2.2 Billion by 2027, growing at a CAGR of 30.7%...
131 pages •
By Global Industry Analysts
• Apr 2021
Abstract:
- Global Healthcare Fraud Detection Market to Reach $5.1 Billion by 2027
- Amid the COVID-19 crisis, the global market for Healthcare Fraud Detection estimated at US$1 Billion in the year 2020, is projected to reach a revised size of US$5.1 Billion by 2027, growing at a CAGR of 25.9% over the analysis period...
348 pages •
By Global Industry Analysts
• Apr 2021
Abstract:
- Global Fermenters Market to Reach $1.9 Billion by 2027
- Amid the COVID-19 crisis, the global market for Fermenters estimated at US$1.2 Billion in the year 2020, is projected to reach a revised size of US$1.9 Billion by 2027, growing at a CAGR of 7.1% over the analysis period 2020-2027. Food, one of the...
144 pages •
By Global Industry Analysts
• Apr 2021
Abstract:
- Global Healthcare Chatbots Market to Reach $536.1 Million by 2027
- Amid the COVID-19 crisis, the global market for Healthcare Chatbots estimated at US$144.3 Million in the year 2020, is projected to reach a revised size of US$536.1 Million by 2027, growing at aCAGR of 20.6% over the period 2020-2027. Symptom...
Healthcare
World
China
United States
By continuing to use this site you consent to the use of cookies on your device as described in our Cookie Policy unless you have disabled them.
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.